Metabolites

Shop By
View as List Grid

8 Items

Set Descending Direction
  1. Adenosine 5′-diphosphate, Agonist of P2Y 11 receptor;Agonist of P2Y 12 receptor;Agonist of P2Y 13 receptor;Agonist of P2Y 1 receptor;Agonist of P2Y 6 receptor;Gating inhibitor of TRPM4
    Cas#: 58-64-0        Compound CID:  6022
    Formula:  C10H15N5O10P2        Molecular Weight: 427.2
    IUPAC Name: [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate
    SMILES: Nc1ncnc2n(cnc12)[C@@H]3O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]3O
    InChIKey: XTWYTFMLZFPYCI-KQYNXXCUSA-N
    InChI: InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
    Synonyms: Adenosine 5'-(trihydrogen diphosphate) | 5'-Adenylphosphoric acid | ADP | Adenosindiphosphorsaeure | ADP (nucleotide)...
  2. Adenosine 5′-diphosphate, Agonist of P2Y 11 receptor;Agonist of P2Y 12 receptor;Agonist of P2Y 13 receptor;Agonist of P2Y 1 receptor;Agonist of P2Y 6 receptor;Gating inhibitor of TRPM4
    Cas#: 58-64-0        Compound CID:  6022
    Formula:  C10H15N5O10P2        Molecular Weight: 427.2
    IUPAC Name: [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate
    SMILES: Nc1ncnc2n(cnc12)[C@@H]3O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]3O
    InChIKey: XTWYTFMLZFPYCI-KQYNXXCUSA-N
    InChI: InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
    Synonyms: Adenosine 5'-diphosphate|Adenosine diphosphate|58-64-0|adenosine-5'-diphosphate|ADP|Adenosine 5'-(trihydrogen diphosp...
  3. 2-oleoyl-LPA, Agonist of GPR35;Agonist of LPA 1 receptor;Agonist of LPA 2 receptor;Agonist of LPA 3 receptor
    IUPAC Name: {3-hydroxy-2-[(9Z)-octadec-9-enoyloxy]propoxy}phosphonic acid
    SMILES: CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO
    InChIKey: ZOOLJLSXNRZLDH-KTKRTIGZSA-N
    InChI: InChI=1S/C21H41O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(23)28-20(18-22)19-27-29(24,25)26/h9-10,20,22H,2-8,11-19H2,1H3,(H2,24,25,26)/b10-9-
  4. UDP, Agonist of GPR17;Activator of K ir6.1;Agonist of P2Y 14 receptor;Agonist of P2Y 6 receptor
    Cas#: 58-98-0        Compound CID:  6031
    IUPAC Name: [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate
    SMILES: O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
    InChIKey: XCCTYIAWTASOJW-XVFCMESISA-N
    InChI: InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1
    Synonyms: Uridine 5'-diphosphate|URIDINE DIPHOSPHATE|58-98-0|uridine-5'-diphosphate|Uridine 5'-(trihydrogen diphosphate)|UDP|5'...
  5. Up₃U, Agonist of P2Y 6 receptor
    IUPAC Name: [[(2R,3R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [[(2S,3S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate
    SMILES: O[C@@H]1[C@H](COP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2ccc(=O)[nH]c2=O)[O-])[O-])[O-])O[C@H](C1O)n1ccc(=O)[nH]c1=O
    InChIKey: JPNWHMPVXHYIKN-VRXVDWQRSA-K
    InChI: InChI=1S/C18H25N4O20P3/c23-9-1-3-21(17(29)19-9)15-13(27)11(25)7(39-15)5-37-43(31,32)41-45(35,36)42-44(33,34)38-6-8-12(26)14(28)16(40-8)22-4-2-10(24)20-18(22)30/h1-4,7-8,11-16,25-28H,5-6H2,(H,31,32)(H,33,34)(H,35,36)(H,19,23,29)(H,20,24,30)/p-3/t7-,8+,11+,12-,13?,14?,15-,16-/m1/s1
  6. farnesyl diphosphate, Agonist of LPA 2 receptor;Antagonist of LPA 3 receptor;Antagonist of LPA 4 receptor;Agonist of LPA 5 receptor;Activator of TRPV3
    Cas#: 13058-04-3        Compound CID:  11132720
    IUPAC Name: phosphono [(2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] hydrogen phosphate
    SMILES: C/C(=C/COP(=O)(OP(=O)(O)O)O)/CC/C=C(\CCC=C(C)C)/C
    InChIKey: VWFJDQUYCIWHTN-FBXUGWQNSA-N
    InChI: InChI=1S/C15H28O7P2/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-21-24(19,20)22-23(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H,19,20)(H2,16,17,18)/b14-9-,15-11-
  7. farnesyl monophosphate, Antagonist of LPA 2 receptor;Antagonist of LPA 3 receptor;Antagonist of LPA 4 receptor;Agonist of LPA 5 receptor
    IUPAC Name: [(2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] dihydrogen phosphate
    SMILES: C/C(=C/CC/C(=C\COP(=O)(O)O)/C)/CCC=C(C)C
    InChIKey: ALEWCKXBHSDCCT-FBXUGWQNSA-N
    InChI: InChI=1S/C15H27O4P/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-19-20(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H2,16,17,18)/b14-9-,15-11-
    Synonyms: SCHEMBL2506806 | FFT | [(2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] dihydrogen phosphate | GTPL2911 | Farnesyl mon...
  8. phosphatidyl (3,5) inositol bisphosphate, Activator of TPC1;Activator of TPC2;Activator of TRPML1;Activator of TRPML2;Activator of TRPML3
    Cas#: 214282-36-7        Compound CID:  643961
    Formula:        
    IUPAC Name: [(2R)-2-hexadecanoyloxy-3-[hydroxy-[(2R,3R,5S,6R)-2,4,6-trihydroxy-3,5-diphosphonooxycyclohexyl]oxyphosphoryl]oxypropyl] hexadecanoate
    SMILES: CCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC)COP(=O)(OC1[C@H](O)[C@H](OP(=O)(O)O)C([C@@H]([C@H]1O)OP(=O)(O)O)O)O
    InChIKey: UZMPYXSDDZXMAI-OHKKONBVSA-N
    InChI: InChI=1S/C41H81O19P3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(42)55-31-33(57-35(43)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)32-56-63(53,54)60-41-37(45)39(58-61(47,48)49)36(44)40(38(41)46)59-62(50,51)52/h33,36-41,44-46H,3-32H2,1-2H3,(H,53,54)(H2,47,48,49)(H2,50,51,52)/t33-,36?,37-,38-,39-,40+,41?/m1/s1
    Synonyms: CHEBI:82954 | 3,5-bis(dihydrogen phosphate) (9CI) | 1,2-diyl dihexadecanoate | DTXSID90349238 | phosphatidyl (3,5) in...
per page

We noticed your location and want to make sure you’re viewing the most relevant version of our site.
Would you like to be redirected to your local region’s page for a smoother experience?